SCHEMBL31201752

SCHEMBL31201752

Cn1nc(Br)nc1Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.41
KLKB1 P03952 1/20 0.39
LMNA P02545 2/20 0.39
LTB4R Q15722 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PIK3CD O00329 1/20 0.39
PIK3R1 P27986 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39
PIK3CG P48736 1/20 0.39
TDP2 O95551 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
CALM1 P0DP23 1/20 0.38
ALDH1A1 P00352 2/20 0.38
KDM4E B2RXH2 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17231383 0.80 ADRB2 (0.44) RXFP1KLKB1LMNALTB4RTDP1
SCHEMBL11583604 0.79 KDM4E (0.51) RXFP1KLKB1LMNALTB4RPIK3CD
SCHEMBL553847 0.75 KLKB1 (0.53) RXFP1KLKB1LMNATDP2KDM4C
SCHEMBL23337069 0.72 KLKB1 (0.54) RXFP1KLKB1LTB4RMEN1KMT2A
SCHEMBL31201754 0.71 TDP2 (0.51) LTB4RTDP1TDP2KDM4CCALM1
SCHEMBL9285055 0.71 GAA (0.47) LMNAALDH1A1KDM4EHSD17B10SMN1; SMN2
SCHEMBL14415474 0.70 TDP2 (0.50) RXFP1LTB4RTDP1TDP2KDM4C
SCHEMBL11295802 0.69 TDP2 (0.49) RXFP1LMNALTB4RTDP2KDM4C
SCHEMBL30993366 0.69
SCHEMBL27217204 0.68 NR1H3 (0.63) TDP2KDM4CHSD17B10MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709725-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF Progentos Therapeutics, Inc. (US) 2026-03-18 EP disclosed
WO-2024233642-A1 HETEROCYCLIC COMPOUNDS AND USES THEREOF PROGENTOS THERAPEUTICS, INC. (US) 2024-11-14 WO disclosed